P. Gerasimou, V. Nicolaidou, N. Skordis, M. Picolos, D. Monos, P. Costeas
{"title":"Combined Effect of Glutamine at Position 70 of HLA-DRB1 and Alaline at Position 57 of HLA-DQB1 in Type 1 Diabetes: An Epitope Analysis","authors":"P. Gerasimou, V. Nicolaidou, N. Skordis, M. Picolos, D. Monos, P. Costeas","doi":"10.37247/paendo.1.2020.2","DOIUrl":null,"url":null,"abstract":"study Abstract The contribution of specific HLA Class II alleles in type 1 diabetes is determined by polymorphic amino acid epitopes that direct antigen binding therefore, along with conventional allele frequency analysis, epitope analysis can provide important insights into disease susceptibility. Within our highly genetically heterogeneous patient cohort we identified a subgroup that did not carry the DRB1*03:01-DQA1*05:01-DQB1*02:01 and DRB1*04:xx-DQA1*03:01-DQB1*03:02 susceptibility epitopes DRB1 Q 70 , DQB1 L 26 and resistance epitopes DRB1 D 70 , R 70 and DQB1 Y 47 . Prevalence of susceptibility epitopes was higher in patients and was not exclusively a result of linkage disequilibrium. Epitopes DRB1 Q 70 , DQB1 L 26 and A 57 and a 10 amino acid epitope of DQA1 were the most significant in discriminating risk alleles. An extended haplotype containing these epitopes was carried by 92% of our patient cohort. Sharing of susceptibility epitopes could also explain the absence of risk haplotypes in patients. Finally, many significant epitopes were non-pocket residues suggesting that critical immune functions exist spanning further from the binding pockets.","PeriodicalId":262831,"journal":{"name":"Prime Archives in Endocrinology","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prime Archives in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37247/paendo.1.2020.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
study Abstract The contribution of specific HLA Class II alleles in type 1 diabetes is determined by polymorphic amino acid epitopes that direct antigen binding therefore, along with conventional allele frequency analysis, epitope analysis can provide important insights into disease susceptibility. Within our highly genetically heterogeneous patient cohort we identified a subgroup that did not carry the DRB1*03:01-DQA1*05:01-DQB1*02:01 and DRB1*04:xx-DQA1*03:01-DQB1*03:02 susceptibility epitopes DRB1 Q 70 , DQB1 L 26 and resistance epitopes DRB1 D 70 , R 70 and DQB1 Y 47 . Prevalence of susceptibility epitopes was higher in patients and was not exclusively a result of linkage disequilibrium. Epitopes DRB1 Q 70 , DQB1 L 26 and A 57 and a 10 amino acid epitope of DQA1 were the most significant in discriminating risk alleles. An extended haplotype containing these epitopes was carried by 92% of our patient cohort. Sharing of susceptibility epitopes could also explain the absence of risk haplotypes in patients. Finally, many significant epitopes were non-pocket residues suggesting that critical immune functions exist spanning further from the binding pockets.
1型糖尿病中特异性HLAⅱ类等位基因的贡献是由直接抗原结合的多态性氨基酸表位决定的,因此,与传统的等位基因频率分析一起,表位分析可以为疾病的易感性提供重要的见解。在我们高度遗传异质性的患者队列中,我们发现了一个不携带DRB1*03:01-DQA1*05:01-DQB1*02:01和DRB1*04:xx-DQA1*03:01-DQB1*03:02易感表位DRB1 Q 70、DQB1 L 26和耐药表位DRB1 D 70、r70和DQB1 Y 47的亚组。患者中易感表位的患病率较高,并不完全是连锁不平衡的结果。DRB1 q70、DQB1 l26和a57表位以及DQA1的一个10个氨基酸表位对危险等位基因的鉴别最显著。我们的患者队列中有92%的人携带含有这些表位的扩展单倍型。易感表位的共享也可以解释患者中风险单倍型的缺失。最后,许多重要的表位是非口袋残基,这表明关键的免疫功能存在于结合口袋之外。